| Low Prevalence of Target Dose Beta Blocker Use in Patients with Reduced Ejection Fraction Heart Failure | Onur YILDIRIM,İrem Müge AKBULUT,Hüseyin GÖKSÜLÜK,Sadi GÜLEÇ | 183–188 |
| Association Between Natriuretic Peptide Levels and Sleep Quality in Patients with Heart Failure | Recep KURT,Anıl ŞAHİN,Hakan GÜNEŞ,Okan Onur TURGUT,Gülaçan TEKİN,MEHMET BİRHAN YILMAZ | 189–196 |
| The Effect of Chronic Total Occlusion of Coronary Artery on Long Term Prognosis in Patients with Ischemic Cardiomyopathy with Impantable Cardioverter Defibrillator | Oğuzhan Ekrem TURAN,Ali Nail KAYA,Armağan KAYA,Yusuf Demir OZAN,Fatih KARTALER,Ayşim DEMİRMAN,Mürsel ŞAHİN,Ömer GEDİKLİ,Mustafa GÖKÇE,Merih KUTLU | 197–204 |
| The Relation of High Levels of Procalcitonin with Lesion Severity in Non ST Segment Elevation Myocardial Infarction Patients | Kerim ESENBOĞA,Nil ÖZYÜNCÜ | 205–210 |
| Comparison of Two Different Types of Stent Platforms with Biolimus Eluting: Three Year Randomized, Prospective, Single Center, Clinical and Angiographic Follow-Up Trial | Veysel Özgür BARIŞ,Demet MENEKŞE GEREDE,Çağdaş ÖZDÖL,Çetin EROL | 211–216 |
| Prediction of the Severity of Coronary Artery Disease of Fibrinogen/Albumin Ratio in Patients with Metabolic Syndrome | Gökhan CEYHUN,Mustafa ÖZTÜRK,Oğuzhan BİRDAL,Muhammed Hakan TAŞ,Esma Selva ATEŞ,Fuat GÜNDOĞDU,Azman ATEŞ | 217–223 |
| Evaluation of Epicardial Fat Tissue and Carotid Intima-Media Thicknesses in Patients with Hypertrophic Cardiomyopathy | Aylin GUNESLİ,Mustafa YILMAZ | 224–229 |
| The Relationship of Red Blood Cell Distribution with Non-Dipper Blood Pressure Pattern in White Coat Hypertension | Abdullah SÖKMEN,Ekrem AKSU,Musa DAĞLI,Enes ÇELİK,Gülizar SÖKMEN | 230–236 |
| Management of a Rare Complication of Pericardiocentesis | GÖKAY TAYLAN,Çağlar KAYA,Melik DEMİR | 237–239 |
| The Relation of ABO Blood Groups to Coronary Artery Disease: A Systematic Review | Serdar TÜRKMEN,Lütfü AŞKIN,Okan TANRIVERDİ | 240–244 |
| Current Approach to Lower Extremity Peripheral Artery Disease |